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Objective: This study investigates the effectiveness of open-ended psychotherapy in a
large, naturalistic, and diverse patient cohort using rigorous and multifaceted assessments.
Method: Patients (N = 370) in open-ended psychotherapy completed an extensive set of
self-report measures and diagnostic interviews, including long-term follow-up in order to
assess stability of outcomes. About half of the patients qualified for a personality disorder
at the onset of treatment. Treatments were open-ended, and on average therapists
provided substantially larger treatment doses than common in the literature.
Results: A substantial majority recovered from their respective Axis I (58%) and/or Axis II
(55%) disorders during treatment. Patients also experienced large positive changes in self-
report measures of overall psychiatric symptoms and moderate positive changes in self-
reported interpersonal problems, while very few (< 3%) demonstrated negative
development. The patients maintained their diagnostic and self-assessed changes at a
two-and-a-half-year follow-up. In contrast, self-reported occupational functioning showed
minimal improvement throughout the treatment and follow-up phase.
Conclusion: A naturalistic patient cohort undergoing open-ended psychotherapy
demonstrates substantial and stable improvements.
Keywords: psychotherapy, representative, effectiveness, outcome, naturalisticINTRODUCTION
A considerable research effort has gone into the empirical investigation of the effects of
psychotherapy. The goal of this research effort is to formulate accurate knowledge, which can
inform health-policy and the practice of psychotherapy in general. One major challenge is to
navigate the need for stringent protocols to increase internal validity on the one hand, with the need
for “representative” research that can generalize to those institutions where the majority of
psychotherapy takes place (1). Studies that seek to assess a treatment under real world conditions
are typically labelled as effectivness trials, in contrast to lab driven efficacy trials. The distinction
between efficacy and effectiveness research is somewhat nebulous as the two terms lack
operationalized definitions. Prominent parameters separating the two include the selection ofg May 2020 | Volume 11 | Article 3841
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of psychotherapy, and the type and amount of therapist training
and monitoring (2). Researchers have demonstrated that these
procedural variables can influence outcomes in a range of
interventions (3). One dramatic example was when Weisz,
Weiss & Donenberg (4) concluded that “most clinic studies
have not shown significant effects” (p. 1578) after reviewing
effectiveness psychotherapy interventions for children and
adolescents. The authors contrasted this finding with evidence
that efficacy trials from the lab consistently produced significant
benefits. Also, what we consider “representative” is a moving
target as in that the treatments delivered in routine practice
change over time and across nationalities and regions.
There are arguably three main methodologies for assessing
representative psychotherapy interventions for adults (5). One is
to compare evidence-based treatments (EBT) with treatment as
usual (TAU) condition (6, 7). If TAU is found to be equally
effective, then this is indirect evidence that the TAU is itself
effective. Wampold et al. (7) used meta-analysis to assess EBT
versus TAU in 14 studies and found that EBT generally
outperformed TAU, but that this difference was most likely an
effect of heterogeneity in the TAU category, which also included
minimal or no treatment. The superiority of EBT disappeared
when the authors compared EBT with TAU conditions that
contained psychotherapy (three studies). In contrast, Budge et al.
(6) found that EBT was significantly more effective in treating
personality disorders when compared to a TAU psychotherapy
condition, although the amount and type of supervision,
therapist training, and therapy dose were not balanced across
the conditions (8).
The second line of research comes from direct benchmarking
studies that make statistical comparisons between the results
from efficacy and effectiveness trials (9). The evidence from
benchmarking studies suggests that routine-care does indeed
produce similar results compared to the lab (10–12). However,
these results are most commonly from patient samples with an
unknown degree of pathology with limited or no diagnostic
assessments. Most studies only supply description of the primary
symptomatic problem. This raises the question of whether
patient characteristics such as severity of pathology or the
presence of characterological problems might influence the
relationship between trial representativeness and outcome.
Lastly, the majority of data from benchmarking trials utilize
treatment data from American university counseling centers
(13). Thusly, these results might not generalize to non-
university clinical settings.
The third line of research uses meta-analytical tools to
investigate representativeness. Shadish et al. (14) categorized
studies with a criterion-based approach. To pass the first
criterion the studies had to be conducted in a non-university
setting, with patients that were referred via traditional routes and
used professionals with regular caseloads. To pass the second
criterion the studies had to pass criterion one and not use a
treatment manual or any monitoring of intervention
implementation. To pass the third criterion the study had to
pass criterion two, use clients that were heterogeneous withFrontiers in Psychiatry | www.frontiersin.org 2respect to presenting problems, personal characteristics and
lastly, not include any explicit therapist training immediately
before the study. From 1,082 possible studies that the authors
included in the initial pool of meta-analyses, only 56 (5.2%)
passed criterion one, 15 (1.4%) studies, passed criterion two and
only one study (0.1%) passed criterion three. That study was a
family therapy intervention for children (n = 11) with behavioral
problems (15). Shadish et al. (14) concluded that criterion one-
studies appear to produce similar effect sizes compared with the
total sample, but that the lack of criterion two and three studies
prohibits strong conclusions regarding the effect of routine-care
versus lab trials. In a follow-up study (3), the authors expanded
the base pool of studies and refined the criteria for
representativeness. In place of the earlier stage system, the
authors took a dimensional approach, coding the degree of
representativeness on a scale from zero to ten. With an
expanded pool of baseline studies, including a set of highly
representative “clinic therapy” (p. 513) studies, as well as a
non-representative set of randomized controlled trials, the
authors found that the effects of psychotherapy were robust
across the spectrum. A regression analysis of the clinical
representativeness features indicated that a large therapy dose,
the presence of an internal control group, homogeneity in
presenting problem, use of structured therapy, and flexibility in
the number of sessions were positively related to effect sizes.
In more recent years, many large-scale randomized pragmatic
trials have been conducted, where the aim is to assess the
effectiveness of a specific EBT in routine care. These generally
support the effectiveness of EBT implemented in routine care (5).
A predicament of the pragmatic trial is that it has to balance the
need for external validity with the necessity of treatment fidelity.
In practice, this means selecting or training therapist to deliver a
particular treatment. The very features that the pragmatic trials
seek to achieve, namely experimental control, make
generalizations to non-EBT clinical settings precarious, although
less so compared to the classical lab-driven RCT. The problem of
generalization is highlighted by evidence suggesting that therapists
seldom implement EBT in their routine care (16). On a related
note, evidence from psychopharmacological research suggests that
effectiveness trials demonstrate lower effects when compared to
their experimental RCT counterparts (17).
Based on this summary of psychotherapy studies under
representative conditions it seems that the majority of evidence
comes from either a synthesis of heterogenic meta-analytic
investigations or from pragmatic trials and benchmarking trials
that assess a specific EBT. This synthesis suggests that
psychotherapy, on the whole, is effective when implemented
under routine-care conditions, but when limiting analyses to
highly representative studies, the evidence is limited. Studies
have typically severely restricted the number of sessions and
rarely provided diagnostic information beyond symptomatic
assessment. These characteristics constitute a challenge as the
severity of psychopathology, and the presence of personality
disorder represent confounding variables. Similarly, “real-world”
effectiveness investigations are almost exclusively from university
counseling centers. Our goal in this study is to assess theMay 2020 | Volume 11 | Article 384
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healthcare setting with a large, heterogeneous sample, including
severe characterological psychopathology. We believe that these
results may serve to supplement a literature that is dominated by
milder varieties of mental problems. Assessments include
rigorous diagnostic interviews as well as patient's self-
assessments, both with a considerable follow-up period beyond
treatment termination. To our knowledge, the effectiveness of
psychotherapy with a representative patient sample, which does
not asses a particular EBT, has not been previously documented
in the psychotherapy literature. In the present paper we answer
the following research questions:
Given an open-ended, naturalistic, and representative
psychotherapy setting,
1. What are the rates and magnitudes of diagnostic,
symptomatic, and interpersonal change?
2. To what degree are therapeutic gains maintained over time?
3. Do patients experience a positive change in occupational
status?METHODS
Study Overview
We adopted treatment data collected in the Norwegian
Multicenter Study of Process and Outcomes in Psychotherapy
(NMSPOP). The NMSPOP is a naturalistic study with a total
sample of outpatients (N = 370) gathered from eight treatment
sites within the Norwegian public health system in the years 1995–
2008. The majority of patients (n = 301) were recruited from
psychiatric outpatient clinics spread across 17 separate Norwegian
clinics. We also gathered data from the Norwegian University of
Science and Technology`s student clinic (patient n = 27). Lastly,
we gathered data from outpatient clinics with physiotherapists
(patient n = 42) undergoing specialization in psychodynamic body
therapy for patients with somatoform disorders (18).
At each of the eight sites, trained coordinators (clinical
psychologist or psychiatrist) were responsible for recruiting
patients and administering the research protocol. We
instructed the coordinators to select patients from their local
population randomly, but also to ensure that roughly half had a
diagnosable personality disorder. We did not apply any formal
randomization procedure. The local coordinators also assessed
the patients. The coordinators were all experienced clinicians
who underwent training using the assessment instruments. The
inclusion policy was liberal, with the following exclusion criteria:
age less than 20 years, active psychosis, drug/alcohol abuse as the
primary problem, need for emergency treatment or
hospitalization, and mental retardation (IQ < 70). These
criteria are in line with commonly used criteria in the
evaluation of patients for individual psychotherapy at
outpatient clinics. The Regional Committee for Medical
Research Ethics in Eastern Norway approved the study.
After receiving information and signing a written consent, the
patients were submitted to a two-step pretreatment assessment.Frontiers in Psychiatry | www.frontiersin.org 3In the first step, patients completed several self-report
questionnaires, including among others a sociodemographic
inventory, occupational functioning, the Symptom Checklist-
90-Revised [SCL-90-R: (19)] and the Inventory of Interpersonal
Problems 64 [IIP 64: (20)]. In the second step, patients
underwent a structured diagnostic assessment by the
coordinator at each site. This assessment comprised of a
Structured Clinical Interview (SCID) based on the Diagnostic
and Statistical Manual of Mental Disorders 4th edition (21)
criteria for Axis I and II disorders. All assessment interviews
and therapy sessions were audio recorded. A subset of the SCID I
and SCID II interviews were blindly double-coded by an
independent professional to assess inter-rater reliability. The
patients were assigned to therapists based on availability after
the initial assessment. Patients completed self-report
questionnaires during treatment after the 3rd, 12th, and 20th
session. Patients completed self-report questionnaires every 20th
session following the 20th session for as long as they received
therapy. Following treatment completion, the coordinator
repeated the diagnostic evaluation with a SCID I and II
interview. The self-report questionnaires were also repeated at
the posttreatment assessment. While some of the patients
completed their postassessments directly after treatment
completion (35%), most completed this assessment a few
months after treatment completion due to practical issues. The
average delay was 9.8 after treatment completion (SD = 25.5,
Median = 2.46). The patients were then assessed with SCID
interviews by the same coordinator and completed self-report
measures six months, one, and two and a half years following the
posttreatment assessment. A subsample (n = 17) of patients also
had a six year follow-up assessment.
The therapists (n = 88) were mainly experienced clinicians
with a mean of 10 years (SD = 6.5) of psychotherapy experience.
All therapist also had postgraduate professional training,
including a mean of 5.9 years (SD = 4.3) of clinical supervision.
Notable exceptions were the physiotherapists (n = 8) and student
therapists (n = 27) who received supervision. The mean number
of patients per therapist was 5.6 excluding the student therapists
where each student saw one patient. Therapists were instructed to
provide their usual therapeutic practice.
Sample Characteristics
The mean sample age was 35.2 (SD = 9.4) years with a majority
of female patients (69.5%). See Table 1 for a description of
pretreatment sample diagnostic status. The mean number of
pretreatment SCID II criteria of personality disorder was 12.7
(SD = 5.8). The pretreatment mean symptom score, as measured
by the Global Severity Index (GSI), was 1.28 (SD = 0.61), while
the mean rating of interpersonal problems (IIP Global) was 1.49
(SD = 0.52). The patients reported that “the problem which you
are now seeking treatment for” had lasted on average 11.7 years
(SD = 9.75). The sample did not include patients who sought
treatment for a primary substance use diagnosis. The Norwegian
healthcare system has a separate subdivision with clinics
specializing in the treatment of primary substance use disorders.
When assessed pretreatment, a subgroup of patients indicated
that they used prescribed medication to treat their psychologicalMay 2020 | Volume 11 | Article 384
TABLE 1 | Changes in occupational status and diagnosis frequency.






Functioning 202 (55 %) 205 (65 %) 190 (65 %)
Non-functioning 154 (42 %) 110 (35 %) 104 (35 %)
SCID1 Diagnosis
Presence of SCID 1 diagnosis 321 (87 %) 119 (40 %) 99 (38 %)
Affective disorders 150 56 42
Anxiety disorders 406 109 84
Somatoform disorders 117 26 23
Eating disorders 31 10 4





Presence of SCID 2 diagnosis 200 (54 %) 84 (28 %) 58 (22 %)
Cluster A 82 31 14
Cluster B 71 24 21
Cluster C 169 62 35
Not Otherwise Specified 2 0 1
*Percentage from total sample (N = 370).
**Percentage from available occupational (n = 315) and diagnostic (n = 297) post-
treatment data.
***Percentage from available occupational (n = 294) and diagnostic (n = 258) follow-up
data.
Nordmo et al. Effectiveness of Open-Ended Psychotherapyproblems either “regularly” (22%) or “when in need” (7%). The
majority of patients using psychotropic medication indicated
that they mainly used an antidepressant (n = 72), while fewer
indicated that they mainly used an anxiolytic (n = 19), a hypnotic
(n = 3), an antipsychotic (n = 4), or pain medication (n = 8). Of
the psychotropic medication users, the majority used a single
medication (n = 70), while some were prescribed two (n = 22),
three (n = 9) or four (n = 4) different medications.
Assessment Instruments
The Symptom Checklist 90 Revised (SLC-90)
We used the SLC-90 to assess overall symptom presence and
severity. It contains 90 questions asking patients to rate, on a
Likert scale from 0 (not at all) to 4 (very much), the intensity of a
given symptom during the last week. The symptoms represent
nine dimensions of distress, which can be further grouped into
three global indexes (22). We used the Global Severity Index
(GSI) as an overall symptom severity measure, which is the mean
rating across the entire checklist. The GSI is a robust measure of
overall symptom severity (23). The SCL-90 demonstrated high
internal validity in our sample with a pretreatment Cronbach's
alpha of.97.
The Inventory of Interpersonal Problems 64 (IIP-64)
We applied the IIP-64 to assess levels of interpersonal problems.
It consists of 64 questions rated on a five-point Likert scale from
0 (not at all) to 4 (very much). The first 39 questions begin with
the phrase “It is hard for me to…” while the remaining 25
questions ask about “Things that I do too much.”We used the IIP
global, which is the mean scores across the entire inventory. This
global score has been shown to adequately capture a wide rangeFrontiers in Psychiatry | www.frontiersin.org 4of interpersonal problems and pathology (24). The IIP-64
demonstrated high internal validity with a pretreatment
Cronbach's alpha of.93.
Occupational Status
We created a dichotomous variable (occupational functioning vs.
no functioning) based on self-reported occupational status. We
classified the following responses as “functioning”: 1) “I am
currently engaged in paid work,” 2) “I am a stay-at-home
mom/dad,” 3) “I am currently engaged as a student” or 4) “I
am retired.” We classified “non-functioning” with the following
responses: 1) “I am currently on sick leave,” 2) “I am currently in
work rehabilitation,” 3) “I am currently receiving disability
benefit” or 4) “I am currently unemployed.” We assessed
changes in occupational status by comparing pre- to
posttreatment levels and pre- to follow-up measurements. We
used the last recorded assessment in our follow up assessment
which was six years for 4.9% (n = 17) of the sample, two and a
half years for 68.6% (n = 254), one year for 5.1% (n = 19) and six
months for 1.0% (n = 4). A total of 20.5% (n = 76) and 14.9% (n =
55) had no follow-up measurement of occupational status at
follow-up and posttreatment respectively.
SCID Interview
The SCID interview was developed for the assessment of both
Axis I clinical disorders (SCID I) and Axis II personality
disorders (SCID II) according to the Diagnostic and Statistical
Manual of Mental Disorders (21). Each disorder is associated
with a set of items that assess different manifestations of the
disorder. Each item can be scored as either absent, sub-threshold,
true, or “inadequate information to code.” The items
corresponding to each particular disorder is then summed to
assess whether the patient qualifies for a given disorder. The
SCID interviews have been shown to give reliable assessments of
DSM-IV diagnoses (25). To assess changes in diagnostic status
for each Axis, we employ a dichotomy between no diagnosis (0)
and one or more diagnoses present (1).
A sample of 40 SCID I and 20 SCID II interviews were
selected at random to assess inter-rater reliability. We found that
Cohen's Kappa for Axis I disorders ranged from.53 to 1.00 with a
mean of.75, indicating fair too excellent agreement. Cohen's
Kappa for Axis II disorders ranged from.63 to 1.00 with a
mean of.82, indicating good to excellent agreement.
Statistical Analysis
We carried out all statistical analyses using R version 3.5.2 (26).
We used the lme4 package (27) to fit linear mixed models, and
lmerTest (28) equipped with Satterthwaite's degrees of freedom
method for p-values. We used ggplot2 (29) and ggalluvial (30) to
make the figures. Imputation was performed using the mice
package (31).
Longitudinal Self-Report Questionnaires
We analyzed the data using Multilevel Modeling (MLM) with
Bayesian Information Criteria (BIC) as our indicator of model fit.
MLM is the recommended method for analyzing longitudinal
and repeated health measures as it allows the nesting of eachMay 2020 | Volume 11 | Article 384
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been shown to outperform traditional methods (e.g., last
observation carried forward method) when handling missing
data and accounting for potential dropout bias (32, 33). For our
treatment phase model, we applied the session number as a fixed
occasion time estimate, as this allows for between-subjects
comparisons of regression coefficients. We centered treatment
start at zero and coded the posttreatment assessment as the last
session number from the longest treatment series, plus 1, which
was 361. For our follow-up model, we centered time as zero at
treatment completion and used month after treatment
completion as our time measure.
We began our analysis by visually inspecting GSI and IIP-
Global raw scores. We observed a log-linear distribution for the
majority of cases on both outcome measures, both in the
treatment- and follow up phase. To assess this, we ran models
with both linear time, where each time-point corresponds to the
specific time of measurement, and with log-transformed time,
where each time-point is multiplied by the log10 to produce a log-
linear curve. These analyses confirmed the superior fit of log-
linear slopes on both our main self-report outcome measures
with lower BIC values as compared to linear time models. The
superior fit of log-time was true for both the treatment phase and
the follow-up phase, although the rate of change was marginal
during follow-up. Another benefit that is of particular
importance in our open-ended design is that log-linear time
places the last observation (e.g., the postmeasurement) closer to
its original time-point, thereby lessening any potential skew
produced coding post time as 361 on patients with short
treatments (34).
Several investigations have shown that latent therapist effects
can influence the statistical modeling of patient trajectories
(35–37). Therefore, in addition to the analyses presented
below, we also carried out a separate three-level (measurements,
patients, therapist) model. This model produced similar overall
results and a poorer BIC value compared to the two-level model
(measurements, patients). We also performed a separate analysis
with patients nested within treatment site, also with very similar
results and worse BIC value, leading us to omit these results.
Effect Sizes and Clinically Significant Change
We used Cohen's d to estimate the magnitude of change by
dividing the estimated change score with the corresponding
pooled standard deviation. The pooled standard deviation was
estimated by taking the mean standard deviation from all
measurement points with more than 150 patients, and merging
the treatment phase and follow-up phase into a single measure.
The pooled standard deviations were 0.56 for GSI and 0.51 for
IIP Global. Our post measurement standard deviations were
counted twice as both the end of the treatment phase, and as the
start of the follow-up phase, corresponding to our two multi-
level models. Using a pooled standard deviation reduces the
problem of artificially inflating the effect size (38). We applied
Cohen's (39) standard for categorizing effect sizes, where 0.2–0.5
is a small effect size, 0.5–0.8 is a moderate effect size, and > .08 is a
large effect size. Clinically significant change was calculated
according to Jacobsen and Truax's (40) definition in which aFrontiers in Psychiatry | www.frontiersin.org 5patient's predicted score needs to achieve both a reliable
statistical change (41) and pass the cut-off to a functional
population as compared to a dysfunctional population. We
used the Norwegian norms from Carrozzino et al. (42) and
Monsen, Hagtvet, Havik, and Eilertsen (43) and calculated these
cut-offs to be 0.73 and 1.22 for the GSI and IIP Global,
respectively. We defined a patient as recovered if he or she met
both criteria. We further categorized patients as reliably
improved if they demonstrated a statistically reliable change,
but failed to cross over the cut-off of dysfunction; unchanged, if
they did not demonstrate a statistically reliable change; or
deteriorated, if a patient showed a negative, statistically reliable
change. We calculated these criteria for both of our main
outcome measures at the end of treatment and the final follow-
up assessment.
Diagnostic and Occupational Status
Using the exact2x2 R package (44), we applied two-sided
McNemar tests with continuity corrections and odds-ratio tests
to analyze changes in diagnostic and occupational status from
pre- to posttreatment, and pretreatment to follow-up status. This
test obtains its respective p-values through central
hypergeometric distribution (45). Both measures were coded as
either 0 (No diagnosis/Functioning) or 1 (Diagnosis/
Non-functioning).
Registration
To increase transparency, we registered our hypotheses and
statistical analyses using the Open Science Framework (46)
before running our analyses. We completed this registration
after the data had been collected and preliminary analyses had
been conducted. The results of the preliminary analyses were
presented at the 39th International Meeting of the Society for
Psychotherapy Research conference. We have made deliberate
efforts to prevent the preliminary analyses from affecting our
current results by not subdividing our data, including all relevant
outcomes measurements and selecting standard statistical tools
for multilevel longitudinal data.RESULTS
Patient Flow and Data Completeness
Out of the original sample of 370 patients, eight did not start
treatment or did not give any assessment following the
pretreatment assessment, giving a total treatment sample of
362. When analyzing diagnostic and occupational follow-up
data, the last available assessment was used. A few patients had
a last measurement of six years (n = 23) after treatment, while the
majority of the patients had follow-up assessments
approximately two and a half years after treatment completion
(Mean = 28.1 months, SD = 8.6). A total of 52 (14.1%) patients
had no follow-up measurement of main outcomes. Logistical
regression was performed on both the GSI and IIP using pre- and
posttreatment scores to predict missing follow-up data. Patients'
pre (p = 0.79) and post (p = 0.55) treatment GSI scores did not
predict missing GSI at follow-up. However, both pre-, c2(1) =May 2020 | Volume 11 | Article 384
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Global scores were statistically significant predictors for missing
IIP Global at follow-up. The multi-level models were fitted with
all available data. The data collection of self-report, diagnostic
and occupational status represents distinct and separate
processes and therefore have distinct attrition patterns. See
Figure 1 for a complete description of patient attrition.
The distribution of therapy length is shown in Figure 2. The
mean number of sessions was 51.3 (SD = 58.9) with a median of
35. A few patients with very long therapies accounted for the
high variance. Every treatment was terminated by a joint
agreement between the therapist and the patient except for
therapy dropouts with one exception: One of the sites
(therapist n = 7, patient n = 31) had an upper-limit of 40 sessions.
Diagnostic and Occupational Status
Table 1 shows changes in diagnostic and occupational status. We
apply the terminology that positive change equals fewer diagnoses.
We found a positive statistically significant difference of any
symptom diagnosis between pre- to posttreatment, x2(1, n =
293) = 128.8, p < 0.01, OR = 19.1, 95% CIs [9.5, 45.1]. We also
found a positive statistically significant change when comparing
presence of any symptom diagnosis pretreatment to follow-up, x2
(1, n = 254) = 109.5, p < .01, OR = 15.1, 95% CIs [7.7, 33.8]. When
applying the same test with the presence of any personality
disorder diagnosis we found the positive changes from pre- to
posttreatment to be statistically significant, x2(1, n = 294) = 59.2,
p < .01, OR = 8.1, 95% CIs [4.3, 16.8]. Lastly we found a positive
statistically significant change in presence of any personality
disorder from pretreatment to follow-up status, x2(1, n = 257) =
65.7, p < .01, OR = 8.2, 95% CIs [4.5, 16.3].
We found that overall, changes in self-reported occupational
status were minimal through the treatment and follow-up phase.
The majority of patients kept their respective status through the
treatment and the follow-up phase, while a substantial minority
went from non-functioning to functioning. Relatively few
patients had a negative development from functioning to non-Frontiers in Psychiatry | www.frontiersin.org 6functioning. See Figure 3 for an alluvial development diagram. A
McNemar test revealed a statistically significant positive change
in occupational functioning from pre- to posttreatment, x2(1, n =
310) = 5.8, p = 0.12, OR = 1.68, 95% CIs [1.1, 2.6], indicating that
more people were able to work posttreatment, compared to
pretreatment. The trend was maintained when we compared
pretreatment to follow-up occupational status, x2(1, n = 291) =
2.4, p =.12, OR = 1.38, 95% CIs [0.9, 2.1].
To account for missing occupational data we performed a
pair of analysis using the Multivariate Imputation by Chained
Equation methodology. Missing occupational data were
imputed by using available diagnostic and occupational
status, gender, GSI, and IIP Global. We created 30 datasets
with a maximum of 20 iterations, using parallel socket cluster.
When analyzing the complete dataset we found that pre- to
posttreatment remained significant, x2(1, nimp = 370) = 6.7,
p = 0.02, OR = 1.56, 95% CIs [1.1, 2.3], as did pre- to follow-














































FIGURE 2 | Treatment length.Patients Enrolled in Project
 N = 370
Available Occupational Data
 (Functioning or Non−Functioning)
Available Self−Report Data
 (SCL−90 & IIP64)
Available Diagnostic Data
 (SCID I & SCID II)
Pre Treatment = 356
Post Treatment = 315
Follow−Up = 294
Pre Treatment = 370
Post Treatment = 362
Follow−Up = 318
Pre Treatment = 358
Post Treatment = 297
Follow−Up = 258
FIGURE 1 | Patient attrition.May 2020 | Volume 11 | Article 384

















































FIGURE 3 | Alluvial diagram of changes in diagnostic and occupational status.Frontiers in Psychiatry | www.frontiersin.org May 2020 | Volume 11 | Article 3847
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Ratio scores.
Change in Symptoms and Interpersonal
Problems During Treatment
The multilevel models from the main outcome treatment phase
are shown in Table 2. We found that scores on the GSI were
subject to a statistically significant change during the treatment
phase when allowing for variable change across patients (Model
1), b = −.18, p < .01. This was also the case for IIP Global (Model
1), b = −.11, p < .01. For the GSI, the overall intercept in the
treatment phase was estimated to be 1.32. Overall change across
the treatment phase was estimated to be a reduction of.47 points.
For IIP Global the overall intercept was estimated to be 1.45 withTABLE 2 | Measures on symptoms and interpersonal functioning in the
treatment phase.
GSI IIP Global
Model 0 Model 1 Model 0 Model 1
Est Est Est Est
Fixed effects
Intercept 1.33** (.03) 1.33** (.04) 1.45** (.03) 1.46** (.03)
Logtime -.186** (.01) -.186** (.01) -.108** (.008) -.113** (.012)
Random effects Est Est Est Est
Residual .14** (.37) .10** (.32) .09** (.30) .07** (.26)
Variance in intercept .31** (.56) .39** (.63) .24** (.49) .027** (.02)
Variance in slopes N/A .04** (.21) N/A .03** (.17)
Intercept Slope Corr. N/A -.43 N/A -.32
BIC 2714.5 2555.8 1952.8 1798.3
Standard error in parenthesis. Estimation performed using Restricted Maximum Likelihood
(REML). Model 0 fixates the rate of change for each patient while Model 1 allows for
variable changes across patients. Fixed effects are presented with the estimate and
standard deviation in parenthesis. Random effects are presented with the variance and
standard error in parenthesis. **p < .01.
Frontiers in Psychiatry | www.frontiersin.org 8a total treatment change of 0.29. There was substantial
heterogeneity across the sample concerning both the GSI and
IIP Global as indicated by the significant variance in the
intercepts. The significant variance in slopes on both main
measures indicates a high degree of variability in treatment
response, which emphasizes the need for multilevel analysis.
The necessity of multilevel analysis is also indicated by the lower
BIC when comparing Model 1, which allows for variable change
across patients, with Model 0, which does not. See Figure 5 for a
visualization of predicted scores.
Symptoms and Interpersonal Problems in
the Follow-Up Phase
The results from the multilevel model of both main outcome
variables during the follow-up phase are shown in Table 3. The
follow-up phase was associated with a small but significant drop
in interpersonal problems as measured by the IIP Global when
allowing for variable changes across patients, b = −.04, p < .001.
The overall intercept was estimated to be 1.19 with a total
reduction of.064. The GSI also show a further reduction, but
this change was not significant b = −.008, p = 0.49. The overall
intercept in the follow-up phase was estimated to be 0.81 with a
total reduction of.012 points. Overall, this indicates that
treatment gains were maintained. The follow-up phase also
showed significant variance in both intercepts and slopes.
Clinically Significant Change
and Effect Sizes
Table 4 shows clinically significant change at the level of the
individual (40). The majority of patients (69%) experienced a
reliable improvement or complete recovery in terms of overall
psychiatric symptoms as measured by the GSI. This symptomatic
improvement was sustained during the follow-up period. For
interpersonal problems, about one third (35%) of the patients
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FIGURE 4 | Odds ratios comparison to pretreatment.May 2020 | Volume 11 | Article 384
Nordmo et al. Effectiveness of Open-Ended PsychotherapyIIP Global revealed fewer complete recoveries compared to the
GSI. During the treatment phase, the GSI change was large (d =
0.85) while the IIP Global change was moderate (d = 0.57). The
follow-up phase showed high stability, with the GSI
demonstrating a weak improvement (d =.03) which was not
statistically significant, while the IIP Global demonstrated a
somewhat stronger improvement (d = 0.13) which was
statistically significant.DISCUSSION
This study shows that patients who receive psychotherapeutic care
in an open-ended outpatient format, experience large to moderate
positive change on self-report measures of overall psychiatric
symptoms and interpersonal difficulties, as well as largeTABLE 3 | Measures on symptoms and interpersonal functioning in the follow-
up phase.
GSI IIP Global
Model 0 Model 1 Model 0 Model 1
Est Est Est Est
Fixed effects
Intercept .82** (.04) .82** (.04) 1.19** (.03) 1.19** (.03)
Logtime -.009 (.01) -.008 (.02) -.042** (.01) -.043* (.01)
Random effects Est Est Est Est
Residual .08** (.28) .07** (.26) .07** (.26) .06** (.23)
Variance in intercept .34** (.58) .38** (.61) .28** (.53) .30** (.55)
Variance in slopes N/A .03* (.17) N/A .02** (.14)
Intercept Slope Corr. N/A -.32 N/A -.22
BIC 1199.8 1191.7 996.9 995.8
Standard error in parenthesis. Estimation performed using Restricted Maximum Likelihood
(REML). Model 0 fixates the rate of change for each patient while Model 1 allows for
variable changes across patients. Fixed effects are presented with the estimate and
standard deviation in parenthesis. Random effects are presented with the variance and
standard error in parenthesis. *p < .05 **p < .01.
Frontiers in Psychiatry | www.frontiersin.org 9observer-rated diagnostic improvements. The majority of
patients do not qualify for an Axis I or Axis II diagnosis at the
end of treatment and can be categorized as either reliably
improved or recovered. Patients experienced a more substantial
reduction in general psychiatric symptom compared to
interpersonal problems which they several years after treatment
termination. During the follow-up phase, the patient's experiences
further positive changes in interpersonal functioning, whereas
they maintained their level of general psychiatric symptoms. The
improvements seen in interpersonal functioning during the
follow-up might be a positive consequence of the open-ended
nature of treatment, where patients and therapists are free to focus
on characterological problems in contrast to manualized, time-
limited and symptom-focused interventions.
As this study is a cohort study without a control group, we
cannot ascertain a causal link between patient improvement and
the psychotherapy received. Due to ethical concerns (47) and







































FIGURE 5 | GSI and IIP Global predicted score distributions.TABLE 4 | Clinically significant change using predicted scores.









Recovered 142 (38 %) 132 (42 %)
Improved 114 (31%) 72 (23 %)
Unchanged 107 (29 %) 103 (32 %)
Deteriorated 6 (1.6 %) 11 (3.4 %)
IIP Global (IIP-64)
Recovered 84 (23 %) 99 (31 %)
Improved 43 (12 %) 42 (13 %)
Unchanged 234 (63 %) 167 (53 %)
Deteriorated 9 (2.4 %) 10 (3.1 %)
* Percentage from total sample (N = 370).
** Percentage from patients with follow-up measure (n = 318).
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psychiatric populations makes it difficult to compare our
treatment sample with a hypothetical no-treatment control.
The studies that do exist are mainly on patients with a mild to
moderate mood and/or an anxiety disorders (49, 50). These
studies suggest that spontaneous recovery for anxiety and mood
disorders is common, but estimates vary greatly between studies.
Spontaneous recovery is documented to be rarer for patients
diagnosed with a comorbid personality disorder (51–54) than for
patients without. There is a lack of data for recovery rates of
severely ill populations that are not in treatment as these
individuals are typically high-treatment utilizers (55). We
would argue that the samples presented in the spontaneous
recovery literature is of milder psychopathology compared to
our sample, where 54% fulfilled the criteria for one or more
personality disorders at admission. The robust positive changes
seen in our sample seems greater than what one might expect
from the rate of natural recovery found in each disorder. We also
believe that the observation that our sample maintained the
therapeutic gains during the follow-up is indicative that positive
changes should be ascribed the therapy received. This lasting
change is contrasted to the chronicity reported pretreatment.
Although randomization to a control condition can open the
road to causal analyses, we believe that that this is precarious for
research on long-term treatments for severely ill patients that
seek to compare routine care and spontaneous recovery. In such
a scenario, the control condition would have to limit or omit
routine care for several years forcefully. This dynamic is also
apparent in the controversy surrounding evidence-based
therapies (56).
The substantial positive changes in overall symptoms and
interpersonal problems did not correspond to an equally
substantial positive change in occupational functioning. The
changes seen in occupational functioning were negligible. This
finding is sharply contrasted by the clinical recovery and
improvements observed for the majority of patients. This
finding is in line with research that indicates that disability
interventions that exclusively focuses on the treatment of a
mental disorder rarely produces occupational recovery (57) as
they overlook the complex interaction of work perceptions and
challenges, attitudes, beliefs and other psycho-social influences
(58, 59). Our findings indicate that patients can improve
substantially, as measured by self-reported mental health
questionnaires and observer-rated psychiatric diagnosis, and
still see a meager degree of positive change in occupational
status. This result should be interpreted with caution as
missing posttreatment and follow-up data obscures the
analysis. Another concern is related to our measurement of
occupational functioning. Returning to work is a complex
phenomenon (60) and a single-item operationalization might
lack the sensitivity to detect intricate changes.
The outcome measure with the most substantial overall
change was psychiatric diagnoses as measured by the SCID
interviews. The majority of patients did not qualify for a
diagnosis after the treatment phase. This improvement was
largely maintained in the follow-up phase and true for bothFrontiers in Psychiatry | www.frontiersin.org 10Axis I and II diagnoses. Previous research has found that
clinicians and independent observers usually report more
substantial positive change when compared to patients
assessing themselves (61, 62). In the present study, an
independent coordinator, and not the respective clinician
performed the diagnostic interviews and assessment, so the
comparison to research on clinician versus patient ratings may
be inaccurate. We believe that the independence of the
coordinators adds to both the validity and reliability of our
diagnostic data.
Using predicted scores, we found a surprisingly low amount
of deterioration (1–3%) compared to what is generally found in
the adult psychotherapy (5–10%) literature (5). We did not
expect low amounts of deterioration as effectiveness
interventions are usually associated with higher rates of
deterioration when compared to structured efficacy trials (63).
We believe that the low rate of deterioration is caused by either of
two explanations or a combination of the two: Firstly, the fact
that this is an open-ended treatment might have given the
therapist the possibility of sustaining treatment until he or she
was convinced that the patient was well enough to terminate
treatment. This feature is in contrast to treatments with a
prescribed set of sessions where a patient might face a setback
or drop in functioning at the end of the prescribed amount of
sessions, thereby giving the patient a negative skew on his or her
predicted slope. Indeed, others have argued that time constraints
can have an impact on successful termination (64). With an
open-ended format, the patient can continue in therapy until the
crises have been overcome and normal functioning has been
established, thereby lessening the negative skew effect of the
transient crises. Indeed, it has been posited that the experience of
control over therapy conditions is directly intertwined with
patient improvement (65).
Limitations and Future Directions
A few limitations should be considered when assessing the
degree of representativeness of our procedures and sample.
Firstly, we did not randomize the selection of therapist to
participate in this trial; rather therapists were self-recruited
based on availability at each site. Second, patients were not
formally randomized to participate in the trial. Instead, the
local administrator of each treatment site was instructed to
pick out patients as randomly as possible, while striving to
provide a representative sample for his or her respective
treatment site. No information was collected from patients
who declined the invitation to participate. Our therapist
sample was comprised mostly of experienced professionals
who volunteered to be a part of an intensive research project.
A potential selection effect could have excluded underperforming
therapist who might have contributed to a higher rate of
deterioration (66).
Another, more substantial question is to what degree this study
captures the elements of what is considered “representative”
psychotherapy practice. This question is hard to answer as
routine care is a moving target that changes with time and across
national and regional borders. Examples of this process can be seenMay 2020 | Volume 11 | Article 384
Nordmo et al. Effectiveness of Open-Ended Psychotherapyin the proposed movement towards evidence-based and stepped-
care treatments initiated with the Improved Access To
Psychological Therapies (IAPT) reform in the UK (67) and its
American (68) and Norwegian (69) equivalent. These are examples
of possible healthcare reform that could substantially change what
we mean by psychotherapy in routine care. The moving target
phenomenon is also evident from the psychotherapy research
literature. Virtually no psychotherapy effectiveness research has
been published in the last ten years when defining effectiveness as
routine care that does not prescribe a specific treatment for a specific
diagnostic population. Therefore, we believe that our results fill an
important missing piece in the current psychotherapy literature. In
our opinion, these results make a fair representation of what one
could expect from the “classical” way of delivering psychotherapy,
where therapists are free to choose the treatment methodology, do
not have a preset time-constraint, and treat each patient
individually, face-to-face. We plan on completing further
moderator analyses in future publications.DATA AVAILABILITY STATEMENT
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